Miocarditis aguda: experiencia con tratamiento inmunosupresor e interferón-1Beta

Gran, Ferran; Martínez Villar, María; Soler Palacín, Pere; Fernández Polo, Aurora; Betrián, Pedro; Albert, Dimpna C.
Rev. esp. cardiol. (Ed. impr.) ; 69(11): 1106-1107, nov. 2016. tab
Artículo en Español | IBECS (España) | ID: ibc-157523

Documentos relacionados

  1. Paediatric viral myocarditis successfully treated with interferon beta-1b and corticoids.
  2. Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study.
  3. Assessment of Medication Adherence Using a Medical App Among Patients With Multiple Sclerosis Treated With Interferon Beta-1b: Pilot Digital Observational Study (PROmyBETAapp).
  4. Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome.
  5. Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World Study.
  6. PASylation technology improves recombinant interferon-ß1b solubility, stability, and biological activity.
  7. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.
  8. A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis.
  9. Assessment of CCL27 and IL-11 in Multiple Sclerosis Patients Treated with Interferon-ß and Glatiramer Acetate.
  10. Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.